Join
Live feed
·
PRReleasevia Quantisnow
Shattuck Labs Inc. logo

Shattuck Labs Announces Phase 2 Clinical Trial of SL-325 in Hidradenitis Suppurativa and Appointment of Shoba Ravichandran, M.D., as Senior Vice President, Clinical Development

ByQuantisnow·Wall Street's wire, on your screen.
STTK· Shattuck Labs Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track STTK (Shattuck Labs Inc.) and more on Quantisnow.